{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:40:21Z","timestamp":1785404421255,"version":"3.56.0"},"reference-count":18,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008130","name":"Pusan National University Hospital","doi-asserted-by":"publisher","award":["202400680001"],"award-info":[{"award-number":["202400680001"]}],"id":[{"id":"10.13039\/501100008130","id-type":"DOI","asserted-by":"publisher"}]},{"award":["202400680001"],"award-info":[{"award-number":["202400680001"]}],"id":[{"id":"https:\/\/ror.org\/027zf7h57","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Placenta accreta spectrum (PAS) is an increasingly prevalent and potentially life-threatening complication in women with placenta previa. Despite widespread clinical use, the inter-modality agreement between prenatal ultrasound and MRI and their comparative value for predicting perioperative hemorrhage remain poorly characterized, particularly in low-to-moderate risk populations where placenta accreta predominates. We aimed to compare inter-modality agreement between standardized ultrasound and MRI impressions and to evaluate each modality\u2019s predictive value for perioperative hemorrhage. Methods: This prospective cohort study enrolled 47 women with placenta previa who underwent both standardized ultrasound and MRI prospectively between 28 + 0 and 32 + 6 weeks of gestation, with perioperative outcomes collected at the time of cesarean delivery. Both modalities were classified using a three-tier impression system (None\/Suspected\/Likely) based on standardized structural, vascular, and invasive marker composites. The primary outcome was inter-modality agreement (linearly weighted Cohen\u2019s \u03ba); secondary outcomes were the association of each modality\u2019s impression with postpartum hemorrhage (PPH; estimated blood loss \u2265 1000 mL) and estimated blood loss (EBL). Results: PAS was confirmed in 18 of 47 women (38.3%), predominantly placenta accreta (83.3%). Inter-modality agreement was fair (weighted \u03ba = 0.263), structural concordance was moderate (\u03ba = 0.539), while vascular agreement was near-absent (\u03ba = 0.085). Ultrasound impression demonstrated a dose-dependent association with PPH rates (38.5%, 52.9%, and 82.4% across None, Suspected, and Likely tiers; p = 0.048) and EBL (800, 1000, and 1800 mL; p = 0.003), with logistic regression confirming a 2.70-fold increase in PPH odds per tier (p = 0.018; AUC 0.657). MRI impression was not associated with PPH (p = 1.000), EBL (p = 0.743), or PAS status (p = 0.741; AUC 0.543). Serum AFP was significantly elevated in women with PPH (p = 0.005). Conclusions: In this accreta-predominant, low-to-moderate risk cohort, ultrasound\u2014but not MRI\u2014demonstrated a significant dose-dependent association with perioperative hemorrhage. These findings should not be interpreted as evidence of general MRI inadequacy but rather as reflecting the specific imaging context in which MRI\u2019s strengths in deep invasion characterization are less clinically determinative. These results support ultrasound as the primary tool for hemorrhage risk stratification in this population.<\/jats:p>","DOI":"10.3390\/diagnostics16131960","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:03:56Z","timestamp":1782349436000},"page":"1960","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ultrasound as the Primary Predictor of Perioperative Hemorrhage in Low-to-Moderate Risk Placenta Accreta Spectrum: A Prospective Comparison with MRI in Women with Placenta Previa"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9107-4296","authenticated-orcid":false,"given":"Sul","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Pusan National University School of Medicine, 179 Gudeok-Ro, Seo-gu, Busan 49241, Republic of Korea"},{"name":"Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojun","family":"Lee","sequence":"additional","affiliation":[{"name":"Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241, Republic of Korea"},{"name":"Department of Radiology, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1223-4387","authenticated-orcid":false,"given":"Hyun-Joo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Pusan National University School of Medicine, 179 Gudeok-Ro, Seo-gu, Busan 49241, Republic of Korea"},{"name":"Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0249-0467","authenticated-orcid":false,"given":"Eun-Hee","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Pusan National University School of Medicine, 179 Gudeok-Ro, Seo-gu, Busan 49241, Republic of Korea"},{"name":"Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6338-1512","authenticated-orcid":false,"given":"Jong-Kil","family":"Joo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Pusan National University School of Medicine, 179 Gudeok-Ro, Seo-gu, Busan 49241, Republic of Korea"},{"name":"Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8174-9931","authenticated-orcid":false,"given":"Seung-Chul","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Pusan National University School of Medicine, 179 Gudeok-Ro, Seo-gu, Busan 49241, Republic of Korea"},{"name":"Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/tmi.12100","article-title":"Prevalence of placenta praevia by world region: A systematic review and meta-analysis","volume":"18","author":"Cresswell","year":"2013","journal-title":"Trop. Med. Int. Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3109\/14767058.2011.553695","article-title":"The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality","volume":"24","author":"Solheim","year":"2011","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijgo.12407","article-title":"FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology","volume":"140","author":"Jauniaux","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2018.09.042","article-title":"Placenta Accreta Spectrum","volume":"219","author":"Cahill","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/1471-0528.12405","article-title":"The management and outcomes of placenta accreta, increta, and percreta in the UK: A population-based descriptive study","volume":"121","author":"Fitzpatrick","year":"2014","journal-title":"BJOG"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists, and Society for Maternal-Fetal Medicine (2018). Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstet. Gynecol., 132, e259\u2013e275.","DOI":"10.1097\/AOG.0000000000002983"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ijgo.12408","article-title":"FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening","volume":"140","author":"Jauniaux","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.09.001","article-title":"Special Report of the SMFM Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum","volume":"224","author":"Bowman","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/uog.13194","article-title":"Prenatal identification of invasive placentation using ultrasound: Systematic review and meta-analysis","volume":"42","author":"Iacovella","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1080\/14767058.2021.1903861","article-title":"The clinical utility of magnetic resonance imaging as an adjunct to ultrasound in the diagnosis of placenta accreta spectrum disorders","volume":"35","author":"Rekawek","year":"2022","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/aogs.13258","article-title":"Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: A systematic review and meta-analysis","volume":"97","author":"Familiari","year":"2018","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/uog.24861","article-title":"Diagnosis of placenta accreta spectrum in high-risk women using ultrasonography or magnetic resonance imaging: Systematic review and meta-analysis","volume":"59","author":"Sarian","year":"2022","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00404-020-05707-y","article-title":"The role of ultrasound in prediction of intra-operative blood loss in cases of placenta accreta spectrum disorders","volume":"302","author":"Hussein","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijgo.12761","article-title":"FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders","volume":"146","author":"Jauniaux","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_15","unstructured":"World Health Organization (2012). WHO Recommendations for the Prevention and Treatment of Postpartum Haemorrhage."},{"key":"ref_16","first-page":"266","article-title":"Placenta accreta is associated with elevated maternal serum alpha-fetoprotein","volume":"82","author":"Kupferminc","year":"1993","journal-title":"Obstet. Gynecol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.kjms.2016.08.011","article-title":"Analysis of first and second trimester maternal serum analytes for the prediction of morbidly adherent placenta requiring hysterectomy","volume":"32","author":"Oztas","year":"2016","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/aogs.14918","article-title":"Evaluation of maternal serum protein biomarkers in the prenatal evaluation of placenta accreta spectrum: A systematic scoping review","volume":"103","author":"Givens","year":"2024","journal-title":"Acta Obstet. Gynecol. Scand."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/13\/1960\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T01:36:24Z","timestamp":1782351384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/13\/1960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":18,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["diagnostics16131960"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16131960","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]}}}